Suivre
Fabrice DENIS MD PhD
Fabrice DENIS MD PhD
Cancérologue, Centre Jean Bernard, Le Mans, France
Adresse e-mail validée de cjb72.org
Titre
Citée par
Citée par
Année
Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced …
F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ...
Journal of clinical oncology 22 (1), 69-76, 2004
10592004
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ...
The Lancet Oncology 19 (4), 521-536, 2018
5392018
Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients
F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ...
JNCI: Journal of the National Cancer Institute 109 (9), djx029, 2017
4472017
Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer
F Denis, E Basch, AL Septans, J Bennouna, T Urban, AC Dueck, ...
Jama 321 (3), 306-307, 2019
4312019
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT …
F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ...
International Journal of Radiation Oncology* Biology* Physics 55 (1), 93-98, 2003
3102003
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
M Di Maio, E Basch, F Denis, LJ Fallowfield, PA Ganz, D Howell, ...
Annals of Oncology 33 (9), 878-892, 2022
1542022
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer
F Denis, AV Desbiez-Bourcier, C Chapiron, F Arbion, G Body, ...
European Journal of Surgical Oncology (EJSO) 30 (10), 1069-1076, 2004
1332004
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ...
The Lancet 393 (10191), 2591-2598, 2019
1292019
What can be learned from a chaotic cancer model?
C Letellier, F Denis, LA Aguirre
Journal of theoretical biology 322, 7-16, 2013
1212013
Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization
S Colas, K Mahéo, F Denis, C Goupille, C Hoinard, P Champeroux, ...
Clinical cancer research 12 (19), 5879-5886, 2006
1152006
Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application
F Denis, S Yossi, AL Septans, A Charron, E Voog, O Dupuis, G Ganem, ...
American journal of clinical oncology 40 (5), 464-469, 2017
1072017
Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer
T Lizée, E Basch, P Trémolières, E Voog, J Domont, G Peyraga, T Urban, ...
Journal of Thoracic Oncology 14 (6), 1012-1020, 2019
942019
Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid
S Colas, L Paon, F Denis, M Prat, P Louisot, C Hoinard, O Le Floch, ...
International journal of cancer 109 (3), 449-454, 2004
932004
Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study)
P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ...
Journal of Nuclear Medicine 58 (7), 1045-1053, 2017
862017
Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up
F Denis, L Viger, A Charron, E Voog, O Dupuis, Y Pointreau, C Letellier
Supportive Care in Cancer 22, 1467-1473, 2014
782014
How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment?
D Ghosh, S Khajanchi, S Mangiarotti, F Denis, SK Dana, C Letellier
BioSystems 158, 17-30, 2017
772017
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer
E Voog, L Campion, P Du Rusquec, H Bourgeois, J Domont, F Denis, ...
Supportive Care in Cancer 26, 81-89, 2018
692018
Early variation of FDG-PET radiomics features in NSCLC is related to overall survival-the “delta radiomics” concept
S Carvalho, RTH Leijenaar, EGC Troost, W Van Elmpt, JP Muratet, ...
Radiother Oncol 118 (suppl 1), S20-S21, 2016
522016
In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours
F Denis, P Bougnoux, L de Poncheville, M Prat, R Catroux, F Tranquart
Ultrasound in medicine & biology 28 (4), 431-437, 2002
512002
OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer
S Supiot, L Vaugier, D Pasquier, X Buthaud, N Magné, D Peiffert, ...
European Urology 80 (4), 405-414, 2021
492021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20